5 Chemicals That Are in (Almost) Everything You Eat

Discover 5 key chemicals that we use to make our food taste the way it’s supposed to taste, look the way we expect it to look, and generally survive the journey to our tables intact.Dooblydoo thanks go to the following Patreon supporters -- we couldn't make SciShow without them! Shout out to Justin Ove, John Szymakowski, Fatima Iqbal, Justin Lentz, David Campos, and Chris Peters.

Spotlight

Ultragenyx Pharmaceutical Inc.

Ultragenyx is a clinical-stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies. Our company is led by an experienced management team in rare disease therapeutics. Recognizing that our primary responsibility is to our patients, we are working with advocacy groups to provide support and outreach to individuals and families affected by these disorders and engage them in the clinical testing process. We are also working with regulatory agencies to design and conduct high quality clinical studies that meet the requirements for approval. We are creating an improved model for successful rare disease d

OTHER VIDEOS

Controlling exothermic reactions with AVA Lab Control Software

video | March 30, 2023

AVA Lab Control Software allows you to automate your chemistry by remotely controlling the devices connected to your jacketed lab reactor with full process data logging....

Watch Now

Processing For Modelling Hydrogen Atoms In Protein Structures

video | March 22, 2023

Neutron Crystallography Data Collection and Processing for Modelling Hydrogen Atoms in Protein Structures....

Watch Now

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling

video | March 17, 2023

Presented here is a phosphoproteomic approach, namely stop and go extraction tip based phosphoproteomic, which provides high-throughput and deep coverage of Arabidopsis phosphoproteome. This approach delineates the overview of osmotic stress signaling in Arabidopsis....

Watch Now

In-cell Fast Photochemical Oxidation of Proteins

video | March 14, 2023

Characterizing Cellular Proteins with In-cell Fast Photochemical Oxidation of Proteins - a 2 minute Preview of the Experimental Protocol...

Watch Now

Spotlight

Ultragenyx Pharmaceutical Inc.

Ultragenyx is a clinical-stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies. Our company is led by an experienced management team in rare disease therapeutics. Recognizing that our primary responsibility is to our patients, we are working with advocacy groups to provide support and outreach to individuals and families affected by these disorders and engage them in the clinical testing process. We are also working with regulatory agencies to design and conduct high quality clinical studies that meet the requirements for approval. We are creating an improved model for successful rare disease d

Events